Cell & Gene Therapy CEO
Date: Location: Cost:
September 25, 2017 Four Seasons Boston
200 Boylston Street
Boston, MA 02116
(617) 338-4400
Location >

Starting at $1950


Dress Code:
Business Attire


Conference Details

Cell & Gene Therapy CEO is an off-the-record networking forum that brings together CEOs and decision makers in cell therapy, gene therapy, and regenerative medicine. Intimate discussion panels, keynotes and fireside chats feature thought leaders debating business model efficiencies, financing, regulatory issues, market access and reimbursement, novel partnerships, manufacturing and delivery challenges. Healthcare investors and leading researchers also participate.

Keynote Speakers Confirmed:
George Church, Professor of Genetics, Harvard Medical School
J. Craig VenterCo-Founder & Executive Chairman, Human Longevity
Michael WestCo-CEO, BioTime

Speakers and Co-Hosts Include: 
Adam Bruce, CEO, Founder & Board Member, TikoMed; Nick Colangelo, CEO, Vericel; John Cox, CEO, Bioverativ; Olivier Danos, CSO, Regenxbio; John Dawson, CEO, Oxford Biomedica; Richard Gaynor, President & CEO, Neon Therapeutics; David Grainger, Partner, Medicxi Ventures; Adam Gridley, President & CEO, Histogenics; Sven Kili, VP, Gene Therapy Development Head, GlaxoSmithKline; Gregory LaRosa, CSO & SVP, Rare Disease Research, Pfizer; Christopher Loose, Co-Founder & CSO, Frequency Therapeutics; Geoff MacKay, President & CEO, AvroBio; James Noble, CEO, Adaptimmune; Amber SalzmanPresident & CEO, Adverum; Alvin Shih, CEO, Enzyvant; Sue Washer, President & CEO, AGTC; Michael West, Co-CEO, BioTime; J. Craig VenterCo-Founder & Executive Chairman, Human Longevity; Luhan Yang, President, CSO & Co-Founder, Egenesis Bio

Supporting Sponsors: (see all sponsors)